FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely paracetamol 48.2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely paracetamol 48.2 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Amoxicillin 125 mg chewable tablet Count of base of active ingredient False un Inferred relationship Some
Amoxicillin 125 mg chewable tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely aripiprazole 15 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely aripiprazole 15 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely citalopram (as citalopram hydrobromide) 40 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely citalopram (as citalopram hydrobromide) 40 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely simvastatin 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely simvastatin 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Ketorolac tromethamine 15.8 mg/actuation nasal spray Count of base of active ingredient False un Inferred relationship Some
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely alprazolam 500 microgram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely alprazolam 500 microgram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Sodium fluoride 5.56 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Sodium fluoride 5.56 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Aripiprazole 30 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Aripiprazole 30 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely paracetamol 120 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely paracetamol 120 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely alprazolam 250 microgram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely alprazolam 250 microgram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible film (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible film (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Pegvisomant 20 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Pegvisomant 20 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Tedizolid phosphate 200 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Tedizolid phosphate 200 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible film (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible film (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cefaclor 125 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely cefaclor 125 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely simvastatin 80 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely simvastatin 80 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Simvastatin 20 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Simvastatin 20 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Cefuroxime (as cefuroxime axetil) 50 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Cefuroxime (as cefuroxime axetil) 50 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
Aminolevulinic acid hydrochloride 200 mg/mL cutaneous solution Count of base of active ingredient False un Inferred relationship Some
Aminolevulinic acid hydrochloride 200 mg/mL cutaneous solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely hydrocortisone 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely hydrocortisone 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Olanzapine 20 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Olanzapine 20 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Alprazolam 2 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Alprazolam 2 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Ethacrynate sodium 50 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Ethacrynate sodium 50 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Asparaginase (as crisantaspase) 10000 unit powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Asparaginase (as crisantaspase) 10000 unit powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely perphenazine 400 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely perphenazine 400 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Belinostat 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Belinostat 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely cefaclor 187 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cefaclor 187 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Alprazolam 1 mg orodispersible tablet Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Alprazolam 1 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Alprazolam 1 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Siltuximab 100 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Siltuximab 100 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ceftibuten 18 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ceftibuten 18 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely desmopressin acetate 150 microgram/1 actuation conventional release nasal spray (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely doxycycline hyclate 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely doxycycline hyclate 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Perphenazine 800 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Perphenazine 800 microgram/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Alprostadil 125 microgram urethral stick Has presentation strength denominator value False un Inferred relationship Some 1
Alprostadil 125 microgram urethral stick Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ceftibuten 36 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ceftibuten 36 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Romiplostim 500 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Romiplostim 500 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely nelfinavir 50 microgram/1 milligram conventional release oral powder (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely nelfinavir 50 microgram/1 milligram conventional release oral powder (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely oxacillin (as oxacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely oxacillin (as oxacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Gemeprost 1 mg vaginal pessary Count of base of active ingredient False un Inferred relationship Some
Gemeprost 1 mg vaginal pessary Has presentation strength denominator value False un Inferred relationship Some 1
Gemeprost 1 mg vaginal pessary Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Metoclopramide (as metoclopramide hydrochloride) 5 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Metoclopramide (as metoclopramide hydrochloride) 5 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Product containing precisely chlorphenamine tannate 800 microgram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely chlorphenamine tannate 800 microgram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1

Start Previous Page 81 of 217 Next End


This concept is not in any reference sets

Back to Start